Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Ann Surg Oncol. 2012 Aug 14;20(1):10.1245/s10434-012-2572-3. doi: 10.1245/s10434-012-2572-3

TABLE 3.

Tumor characteristics and treatment courses for 11 patients with local recurrence

Site Max size
(cm)
Margin
status
Grade RT CT Time to first local
recurrence (mo)
No. of local
recurrences
Distant
metastatic
disease
Treatment of local recurrence Status
UE-P 10 <1 mm 3 Pre 13 3 (1) EBRT/resection/brachytherapy, (2)
 resection, (3) amputation
DOD
LE-P 15.5 >1 mm 3 Pre Pre/post 16 1 Lung Resection DOD
LE-P 2.2 >1 mm 3 Pre/post Post 45 1 Lung, brain Resection DOD
LE-P 10.5 Positive 3 Pre/post 36 2 Lung (1) Resection + IORT, (2) amputation DOD
Trunk 10 <1 mm 2 Pre/IORT 10 1 Open biopsy only DOD
Breast 7 >1 mm 3 17 1 Resection/EBRT NED
UE-D 2.5 Positive 3 6 1 Resection/brachytherapy NED
UE-D (R) 5.5 Positive 2 12 2 (1) Resection, (2) amputation DOD
LE-P (R) 2 Positive 3 85 3 (1) EBRT/resection/boost, (2) resection/
 brachytherapy, (3) resection
NED
LE-D 1.5 <1 mm 2 8 1 EBRT/resection NED
Trunk 6 Positive 3 Pre/post 35 1 EBRT only NED

RT radiotherapy, CT chemotherapy, Pre/Post sequencing with surgery (before or after), UE-P upper extremity—proximal, UE-D upper extremity—distal, LE-P lower extremity—proximal, LE-D lower extremity—distal, (R) recurrent tumor, IORT intraoperative radiotherapy, EBRT external-beam radiotherapy, DOD dead of disease, NED no evidence of disease